Lv11
40 积分 2022-10-26 加入
Clinical Features and Treatment Response in Immune-Mediated Small Fiber Neuropathy with Trisulfated Heparin Disaccharide or Fibroblast Growth Factor Receptor 3 Antibodies
1个月前
已完结
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience
1个月前
已完结
Clinical Features and Treatment Response in Immune-Mediated Small Fiber Neuropathy with Trisulfated Heparin Disaccharide or Fibroblast Growth Factor Receptor 3 Antibodies
1个月前
已关闭
A double‐blind placebo‐controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS‐HDS and FGFR‐3 autoantibodies
1个月前
已完结
Immune-Mediated Small Fiber Neuropathy With Trisulfated Heparin Disaccharide, Fibroblast Growth Factor Receptor 3, or Plexin D1 Antibodies: Presentation and Treatment With Intravenous Immunoglobulin
1个月前
已完结
Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China
2个月前
已完结
Anti-Sez6l2 antibodies, detected in the immune-mediated cerebellar ataxia patient, identify the extracellular domain of Sez6l2 and inhibit complex formation of GluR1, Sez6l2 and ADD
2个月前
已完结
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases
2年前
已完结
皖公网安备34019202002308
